Journal article
Randomized, double-blind study of sonidegib (LDE225) in patients (pts) with locally advanced (La) or metastatic (m) basal-cell carcinoma (BCC)
-
Migden, Michael Robert
The University of Texas MD Anderson Cancer Center, Houston, TX
-
Guminski, Alexander David
Royal North Shore Hospital, St Leonards, Australia
-
Gutzmer, Ralf
Medizinische Hochschule Hannover, Hannover, Germany
-
Dirix, Luc Yves
Sint-Augustinus Ziekenhuis, Wilrijk, Belgium
-
Lewis, Karl D.
University of Colorado Cancer Center, Aurora, CO
-
Combemale, Patrick
Centre Léon Bérard, Lyon, France
-
Herd, Robert
Glasgow Royal Infirmary, Glasgow, United Kingdom
-
Gogov, Sven
Novartis Pharmaceuticals AG, Basel, Switzerland
-
Yi, Tingting
Novartis Pharmaceuticals Corporation, East Hanover, NJ
-
Mone, Manisha
Novartis Pharmaceuticals Corporation, East Hanover, NJ
-
Kudchadkar, Ragini Reiney
University of South Florida, H. Lee Moffitt Cancer Center, Tampa, FL
-
Trefzer, Uwe
Charité Campus Mitte, Berlin, Germany
-
Lear, John
Manchester Royal Infirmary, Manchester, United Kingdom
-
Sellami, Dalila B.
Novartis Pharmaceuticals Corporation, East Hanover, NJ
-
Dummer, Reinhard
Universitätsspital Zürich - Skin Cancer Center University Hospital, Zürich, Switzerland
Show more…
Published in:
- Journal of Clinical Oncology. - American Society of Clinical Oncology (ASCO). - 2014, vol. 32, no. 15_suppl, p. 9009a-9009a
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/50884
Statistics
Document views: 16
File downloads: